RE: Investors Chronicle 30.00 + 2,364.1%19 Feb 2026 18:39
Surfie- I Have no idea but never say never these days as ive been proved wrong on countless occasions on AIM stock (Wild West)! In my humble opinion it all in the hands of the commercial partners, mainly Haleon & what their plans are for Eroxon. The fact still remains it works on 60% of men with ED, issue is not as good as the tablets in higher strength.
I repeat a previous fact that Haleon took sensodyne from 5% market share to over 20% in over two decades, question is what can they do with Eroxon?